Answers are grounded in this paper and cite their sources.
Our clinical experience supports the use of HFNC as first line-therapy in patients with SARS-COV-2 pneumonia for whom face mask oxygen does not provide adequate respiratory support.
No takes yet. Share an insight, caveat, or question.
Béduneau et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: